🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Niemann-Pick disease, type C (NPC) is a lethal, autosomal recessive, lysoso...
Status
Completed
Location
St. Louis Children's Hospital
Start Date
2019-02-22
Trial ID
NCT03471143
Treatments Being Tested
Approximately 90 patients, aged 50 to 80 years, with a diagnosis of early A...
Status
Unknown
Location
Access Research Institute
Start Date
2022-09-23
Trial ID
NCT05607615
Treatments Being Tested
This research study is being conducted to find out whether Trappsol® Cyclo™...
Status
Completed
Location
UCSF Benioff Children's Hospital Oakland
Start Date
2017-10-11
Trial ID
NCT02939547
Treatments Being Tested
The coprecipitation method was used to prepare hydroxypropyl-beta-cyclodext...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT02418676
Treatments Being Tested
Study to assess safety, tolerability and pharmacokinetics (PK) of single in...
Status
Completed
Location
Multiple Locations
Start Date
2002-04
Trial ID
NCT02224079
Treatments Being Tested
Due to different study designs, the sponsor separated Part C into a separat...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-10
Trial ID
NCT02534844
Treatments Being Tested
This study was amended from expanded access to a clinical trial. Informatio...
Status
Terminated
Location
University of Arkansas System
Start Date
2018-06-18
Trial ID
NCT03643562
Treatments Being Tested
About 80% of the worldwide population is positive on HSV antibodies. In the...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT00914745
Treatments Being Tested
A prospective, randomized, double-blind, placebo controlled, multi-center t...
Status
Unknown
Location
UCSF Benioff Children's Hospital Oakland
Start Date
2021-07-20
Trial ID
NCT04860960
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, and pharma...
Status
Completed
Location
Nucleus Network Pty Ltd,
Start Date
2022-02-09
Trial ID
NCT05033444